Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 804 across all filing types
Latest filing 2021-04-29 AGM Information
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
Održana sjednica NO 29.04.2021.
AGM Information Classification · 99% confidence The document is very short (763 characters) and announces that the Supervisory Board approved the non-consolidated and consolidated financial statements for the period 01.01.-31.03.2021, as determined by the Management Board. This announcement is made on April 29, 2021. Since the document itself is merely an announcement about the approval of financial statements for a specific interim period (Q1 2021) and does not contain the full details of those statements, it fits the description of an announcement regarding financial results or reports. Given the content relates to interim financial statements (Q1), the most appropriate classification is Interim / Quarterly Report (IR) if it were the report itself, or an Earnings Release (ER) for highlights. However, because this is a very brief notice *about* the approval of the financial statements, and not the statements themselves or a detailed earnings release, it strongly aligns with the 'Menu vs Meal' rule suggesting a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content is specifically about the approval of financial statements, and not just the publication timing, and it's not a full report, I will classify it as an Earnings Release (ER) as it pertains to the results of the first quarter, even if it's just the approval notice, or potentially RNS. Given the context of financial results approval, ER is a strong candidate, but RPA is also plausible if it's just a notice that the results are ready. Since it mentions the specific period results (01.01.-31.03.2021), it relates directly to earnings. I will lean towards ER as it is an announcement related to the period's financial results, even if brief, and it is not a generic regulatory filing.
2021-04-29 Croatian
Obavijest o vlastitim dionicama
Transaction in Own Shares Classification · 98% confidence The document is titled "PREDMET - OBAVIJEST O VLASTITIM DIONICAMA" (SUBJECT - NOTICE ON OWN SHARES) and explicitly reports on the number of own shares held by the issuer (2940 shares, 9.7370% of capital) and confirms that there is no share buyback program or employee share ownership program. This directly relates to the company's treasury stock activities. Based on the provided definitions, the category 'Transaction in Own Shares' (Code: POS) is the most appropriate fit for reporting on the holding or transaction of treasury stock.
2021-04-29 Croatian
Održana sjednica Uprave 28.04.2021.
Report Publication Announcement Classification · 99% confidence The document is very short (770 characters) and explicitly states that the unaudited non-consolidated and consolidated financial statements for the period 01.01.-31.03.2021 were adopted by the Management Board on April 28, 2021, and will be reviewed by the Supervisory Board on April 29, 2021. This structure—announcing the adoption of financial results for a specific period (Q1 2021) but not containing the full financial data itself—strongly suggests an announcement about the results. Since the text is brief and serves as a notification that the results have been prepared/adopted, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results (key highlights only, or in this case, the adoption of the report). It is not the full Interim Report (IR) or Annual Report (10-K). Given the context of reporting quarterly results, ER is the most appropriate classification over RPA, as it is announcing the results themselves, not just the publication date of a larger document.
2021-04-28 Croatian
Najava sjednice Nadzornog odbora 29.04.2021..pdf
Report Publication Announcement Classification · 99% confidence The document is a short announcement (825 characters) from MEDIKA d.d. dated April 26, 2021. The subject is 'PREDMET – NAJAVA SJEDNICE NADZORNOG ODBORA' (SUBJECT – NOTICE OF SUPERVISORY BOARD MEETING). The text explicitly states that the Supervisory Board meeting will be held on April 29, 2021, to discuss financial reports for the period 01.01.-31.03.2021. This is not the financial report itself, but an announcement about an upcoming meeting where financial results (Interim/Quarterly results) will be reviewed. Since it is an announcement regarding the timing/agenda of a future event where reports will be discussed, and it doesn't fit the specific definitions for ER (Earnings Release - which is the initial announcement of results), or IR (Interim Report - the comprehensive report itself), the most appropriate classification based on the provided definitions and the 'MENU VS MEAL' rule (short announcement about future events/reports) is Report Publication Announcement (RPA) or Regulatory Filing (RNS). Given that it is a formal notice about a board meeting agenda that includes financial review, RPA is slightly more specific than the general RNS fallback, as it announces the context for future report publication/review. However, since the core content is a notice of a meeting agenda, and not explicitly announcing the publication of a document, RNS (Regulatory Filings) serves as a safe fallback for formal corporate governance notices that don't fit other specific categories like DIRS, DIV, or MANG. Given the context of announcing a board meeting agenda, RNS is the most suitable general regulatory announcement category when RPA (which usually announces the release of a document) doesn't perfectly fit the action described.
2021-04-26 Croatian
Najava sjednice Uprave 28.04.2021..pdf
Regulatory Filings Classification · 95% confidence The document is a short announcement (819 characters) dated April 26, 2021, from MEDIKA d.d. The subject is 'PREDMET – NAJAVA SJEDNICE UPRAVE DRUŠTIVA' (SUBJECT - ANNOUNCEMENT OF THE MANAGEMENT BOARD MEETING). The text explicitly states that the Management Board meeting will be held on April 28, 2021, to discuss financial reports for the period 01.01.-31.03.2021. This is not the financial report itself, but an announcement about an upcoming meeting where financial results will be reviewed. This fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), as it announces the review/release of financial information. Since it specifically announces the review of financial reports (which are likely to be released shortly after or during the meeting), and it is a very short notice, RPA is a strong candidate, but given the content is about an internal management board meeting agenda rather than the publication of an external report, RNS (Regulatory Filings - general regulatory announcements) is a safer fallback, or RPA if we interpret the announcement of the review as the publication event. Given the options, and the fact that it's a formal notice about an upcoming event where reports will be discussed, it is best classified as a general regulatory announcement (RNS) or potentially a Management Report (MDA) precursor, but MDA is for the management's explanation of results, not the announcement of the meeting itself. Following the 'MENU VS MEAL' rule, since it's a short announcement about future events/reports, RNS is appropriate as a general regulatory notice.
2021-04-26 Croatian
Obavijest o promjeni člana NO
Board/Management Information Classification · 99% confidence The document is very short (788 characters) and its subject line is "PREDMET – OBAVIJEST O PROMJENI ČLANA NADZORNOG ODBORA" (SUBJECT – NOTICE OF CHANGE IN SUPERVISORY BOARD MEMBER). The text explicitly states that Mrs. Gracijela Balaban ceased to be a member and Mr. Antonio Samaržija became a member of the Supervisory Board. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-04-07 Croatian

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.